Comparison of atropine with ipratropium bromide in patients with reversible airways obstruction unresponsive to salbutamol

Bruge, P.; Harries, Mark; I'Anson, Elizabeth

doi:10.1016/0007-0971(80)90052-2

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1986

2004

Publication Types

Select...

Article3

Book2

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 17 publications

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

Pharmacotherapy for Asthma and Chronic Obstructive Pulmonary Disease

Skorodin

1993

Arch Intern Med

View full text Add to dashboard Cite

A number of new medications for treatment of asthma and chronic obstructive pulmonary disease have been developed in recent years. However, serious issues persist in the management of these illnesses. Prevalence, morbidity, and mortality of asthma are increasing despite the introduction of these new agents. Airflow obstruction is only partially reversible in chronic obstructive pulmonary disease, and drug treatment can only mitigate disability incompletely. Drug toxicity is also an important concern. The five classes of agents (beta-adrenergic agonists, anticholinergic agents, theophylline, cromolyn, and corticosteroids) available for treatment are examined in this review, emphasizing efficacy and toxicity. Less commonly used agents and newly developed compounds that are still investigational are also discussed.

show abstract